We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ECX:NASDAQECARX Holdings Inc. Analysis

Data as of 2026-08-31 - not real-time

$1.04

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind ECARX Holdings Inc. is bearish at $1.04, with short-term averages lagging the long-term ones. It has lost 3.7% over the past 30 days. Momentum indicators put RSI at 42.5 (neutral) with MACD reading bearish. The recent range runs from support at $1.00 up to resistance at $1.18.
Multiples put this in undervalued territory at a P/E of 13.9. The average analyst target implies 193.5% above today's level. Revenue is growing at 47.5% on a -2.3% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 46.7%, a beta of 1.44 and a maximum drawdown of 66.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.

Top Market Events

Updated Aug 5, 2026 0 LONDON, Aug. 5, 2026 /PRNewswire/ -- ECARX Holdings Inc. Nasdaq: ECX "ECARX" or the "Company" , a...ECARX Holdings Inc. Nasdaq: ECX recognises today's key update from SiEngine Technology Co., Ltd., its incubated...Updated Jul 28, 2026 0 LONDON, July 28, 2026 /PRNewswire/ -- ECARX Holdings Inc.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 1.38
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 1.38
  • Analyst targets imply +193.5% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Negative profit margin of -2.3%
  • Analyst targets imply +193.5% versus the current price
  • Revenue growth of +47.5%

Key Metrics & Analysis

Financial Health

Revenue Growth47.50%
Profit Margin-2.25%
P/E Ratio13.9
ROA-0.44%
P/B Ratio-1.5

Technical Analysis

TrendBearish
RSI42.5
Support$1.00
Resistance$1.18
MA 20$1.08
MA 50$1.12
MA 200$1.38
MACDBearish
VolumeDecreasing
Fear & Greed Index94.79

Valuation

Target Price$3.05
Upside/Downside193.51%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.44
Volatility46.67%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.